COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

202312_BB_Slimming Secrets_823x462.png

In the quest for effective weight management, traditional methods often take center stage — balanced diets, regular exercise and lifestyle changes. However, emerging research suggests that certain nutritional and pharmaceutical ingredients, such as berberine, alpha-lipoic acid, oxytocin and topiramate, may each in their own way offer alternative avenues for those seeking additional support in their weight loss journey.

202311_Blog_EctoSeal-Image.jpg

EctoSeal P2G, our revolutionary powder-to-hydrogel base, is the first natural, biodegradable polymer base created for wound care preparations. Read about the motivation behind its development, as well as clinical applications, from PCCA Clinical Compounding Pharmacist Mark Gonzalez, PharmD.

202309_BB_Covid-Vertigo_823x462.png

Multiple studies indicate some patients with COVID-19 infection may develop vertigo. Read how betahistine helped relieve symptoms of vertigo in these post-COVID patients.

202303_Blog-Backed-By Science_1768x923.jpg

Access scientific studies, which include images and videos, conducted by PCCA researchers that evaluated properties and performance of SuspendIt Anhydrous.

202210_Oct_Blog_Maria_1768x923.jpg

PCCA Manager of Science Maria Carvalho discusses presenting 40 Stability Stuies on SuspendIt at International Scientific Conferences.

Glycopyrrolate_Lollipops_for_Adults_and_Topical_Fluoxetine_for_Cats_New_Case_Studies.jpg

Two recent compounding case studies describe treatments that helped adults with persistent drooling as well as cats with behavioral issues.

Recent_Product_Development_Clinical_Research_and_Formulation_Studies_from_PCCA.jpg

PCCA's Chief Scientific Officer Gus Bassani provides an important and exciting update regarding the work of our Research and Development department over the last 18 months.

Scientific_Posters_Supporting_the_Safety_and_Efficacy_of_Compounds.jpg

Maria Carvalho, Manager of PCCA Science, explains scientific poster presentations and why they are important when it comes to peer-reviewed research of pharmacy compounding

USP-NF_and_US_Pharmacist_Featuring_Proprietary_PCCA_Bases.jpg

Maria Carvalho discusses the latest versions of the USP (43rd edition) and NF (38th edition), as well as the corresponding USP Compounding Compendium, recognizing the importance of several proprietary PCCA bases

Low-Dose_Naltrexone_in_Dermatological_Compounding.jpg

Nat Jones, one of PCCA's Clinical Compounding Pharmacist, discusses the importance of naltrexone and how compounders can use Low-Dose Naltrexone therapy, especially with dermatological health challenges.